Cliniphar (TSE:432A) Total Assets: 円2,601 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:432A Cliniphar Ltd TSE:432A
20 GF Score
Price 円1,450.00
! 3 Warning Signs
View Full Analysis

What is Cliniphar Total Assets?

Cliniphar TSE:432A 20 Total Assets is 円2,601 Mil as of Mar. 2026. GuruFocus rates TSE:432A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Cliniphar's Total Assets for the quarter that ended in Mar. 2026 was 円2,601 Mil.

During the past 12 months, Cliniphar's average Total Assets Growth Rate was -23.60% per year.

Total Assets is connected with ROA %. Cliniphar's annualized ROA % for the quarter that ended in Mar. 2026 was 6.12%. Total Assets is also linked to Revenue through Asset Turnover. Cliniphar's Asset Turnover for the quarter that ended in Mar. 2026 was 1.41.

Cliniphar  (TSE:432A) Total Assets Explanation

Total Assets is connected with ROA %.

Cliniphar's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=161.012/( (2662.045+2600.67)/ 2 )
=161.012/2631.3575
=6.12 %

Note: The Net Income data used here is one times the annual (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Cliniphar's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Mar. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=3700.714/( (2662.045+2600.67)/ 2 )
=3700.714/2631.3575
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Cliniphar Total Assets Related Terms

Cliniphar Total Assets Historical Data

* Premium members only.

The historical data trend for Cliniphar's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cliniphar Total Assets Chart

Cliniphar Annual Data
Trend Mar24 Mar25 Mar26
Total Assets
2,279.90 2,662.05 2,600.67

Cliniphar Semi-Annual Data
Mar24 Mar25 Mar26
Total Assets 2,279.90 2,662.05 2,600.67
TSE:432A
20GF Score
Cliniphar Ltd TSE:432A
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cliniphar Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Cliniphar's Total Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (A: Mar. 2026 )+Total Liabilities (A: Mar. 2026 )
=1244.044+1356.626
=2,601

Cliniphar's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=1244.044+1356.626
=2,601

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of 円2,601 Mil mean?
Cliniphar (TSE:432A) has a Total Assets of 円2,601 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Cliniphar and its competitors.
Is Cliniphar's Total Assets too high?
Cliniphar's current Total Assets is 円2,601 Mil. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's Total Assets compare to competitors?
Cliniphar's Total Assets of 円2,601 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Healthcare Providers & Services company?
A good Total Assets depends on the Healthcare Providers & Services industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Cliniphar and its competitors. Cliniphar's current Total Assets is 円2,601 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current Total Assets of 円2,601 Mil. The current Total Assets is 円2,601 Mil. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current Total Assets is 円2,601 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cliniphar Business Description

Address 1-7-31, Otemae, 5th Floor, OMM Building, Otemae, Chuo-ku, Osaka-shi, Osaka, JPN, 540-0008
Cliniphar Ltd is engaged in Pharmaceutical Wholesale and Distribution Business for Domestic and International Markets.
20GF Score

Get the complete analysis for TSE:432A

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,450.00
Price